Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.

The Department of Cardiothoracic Surgery is a recognized leader in heart, lung and esophagus surgery. Our experience with complex cardiothoracic issues and knowledge of the latest advances have helped to establish NewYork-Presbyterian|Weill Cornell Medicine as a major referral center for cardiovascular and thoracic patients from around the world.

2023 CT Surgery group photo

Cardiac Surgery

The Division of Cardiac Surgery provides expert care to patients who need:

  • Coronary Artery Bypass Surgery
  • Valve repair/replacement
  • Aortic Aneurysm & Dissection Repaire
  • Minimally Invasive & Robotic Heart Surgery
  • Ventricular Assist Device & Heart Transplant
Learn More
Cardiac Surgery team

Thoracic Surgery

The Division of Thoracic Surgery offers the most advanced surgical care for:

  • Lung & Esophageal cancers
  • Thymoma
  • Achalasia
  • Hyperhidrosis
  • Hiatal Hernia
  • Lung Volume Reduction for Emphysema
  • Tracheobronchomalacia (TBM)
Learn More
Thoracic Surgery team

Why Choose Weill Cornell?

NewYork-Presbyterian & Weill Cornell Medicine - Cardiothoracic Surgery

New Advances

Up and-coming Bronchoscopic Ablation Therapies for Treatment of Lung Cancer

Click here to lean more about Dr. Ali and Dr. Musani's article

Robotic Bronchoscopy: A Major Advance in the Diagnosis and Treatment of Early-Stage Lung Cancer

Dr. Ali and Dr. Shostak


Robotic technology isn’t replacing doctors; 
it’s helping them do what they do more safely and with greater control and precision than anyone could have imagined a few short years ago.

“That’s why robotic bronchoscopy is such a game-changer,” Dr. Shostak continues. “It’s like a GPS system that gives us a virtual map telling us which way to turn next as we ‘drive’ through that maze of subdividing airways. And because the robot-assisted method allows us to travel deep into the lung and identify hard-to-reach, potentially cancerous nodules, we can perform biopsies with greater precision and lower complication rates than was previously possible. 

“Our ability to perform robotic bronchoscopy, biopsy and surgical removal of cancerous nodules in one procedure shortens the treatment time window from 90 to 25 days,” Dr. Ali says. “That’s a 3-fold decrease”—one that translates to earlier diagnosis and treatment and to significantly improved survival rates. 

Click here to learn more 

WCM's Updates in Interventional Pulmonology Symposium: The Era of Robotics

Click here for more details

Dr. Iosif Gulkarov Named Chief of Cardiothoracic Surgery at NewYork-Presbyterian Queens

Dr. Iosif M. Gulkarov

Iosif Gulkarov, M.D.

Dr. Iosif Gulkarov, a leading adult cardiac surgeon, has been appointed chief of cardiothoracic surgery at NewYork-Presbyterian Queens, effective Oct. 1. Dr. Gulkarov was also recruited to Weill Cornell Medicine as an associate professor of clinical cardiothoracic surgery.

Click here to learn more

Clinical Trials

The Cardiothoracic Surgery Department conducts a robust clinical trials program to evaluate the effectiveness of new treatments and medications that have the potential to improve the management of patients with heart, lung, and esophageal disease. The outcomes of heart, lung, and esophageal operations can be improved with technical innovations.

Current Clinical Trials

 

US News Cardiology & Heart Surgery Badge Best regional hospital 2022                       

Ranked #4 in Adult Cardiology & Heart Surgery Hospital in the nation and #1 in NYC by U.S. News and World Report

Ranked #1 in Best Regional Hospitals in U.S. News

          

      America's 50 best cardiac surgery 2021-2023              America's 100 best cardiac care 2022-2023

America’s 50 Best Hospitals for Cardiac Surgery Award™ by Healthgrade

America’s 100 Best Hospitals for Cardiac Care Award™ by Healthgrade

Check out our X feed for the latest news.